Skip to content

The Effect of Music Meditation Therapy in Patients With Chronic Pain Receiving Botox

The Impact of Music Meditation Therapy on Pain, Mood, and Stress When Botulium Toxin (Botox) Injection is Utilized: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03532607
Enrollment
98
Registered
2018-05-22
Start date
2015-12-31
Completion date
2020-04-30
Last updated
2019-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Chronic

Brief summary

The purpose of this pilot study is to examine the impact of music meditation therapy session on patients with chronic pain who are receiving Botox injections at a pain management center.

Detailed description

This study is a randomized controlled trial (RCT) that employs a two-arm parallel-group design. Ninety-eight participants scheduled to receive a Botox injection will be randomly assigned to receive individual music meditation therapy intervention group or standard care control group before the participant's Botox injection. The study team will use an embedded mixed methods study that uses both quantitative and qualitative data. Qualitative data play a supporting role and are embedded within a larger RCT. The qualitative data will help the investigators better understand the patients' experience of the interventions.

Interventions

OTHERMusic

Patients will listen to soothing music for 30 minutes before their standard of care botox injection

Sponsors

Rowan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients of both genders ages 18-60 who have been referred for Botox injection for treatment of chronic pain at the Rowan SOM NeuroMusculoskeletal Institute. These patients will have a prior diagnosis made by their physicians necessitating treatment with Botox injections. * Patients who have previously received a Botox injection or patients receiving Botox injections for the first time can participate.

Exclusion criteria

* Patients who cannot speak or understand English for informed consent and patient teaching * Patients with hearing impairment. * Pregnant women, children and/or minors, cognitively impaired patients or the elderly (above 60 years of age).

Design outcomes

Primary

MeasureTime frameDescription
Pain Visual Analogue Scale (VAS)3 minutesThe VAS is a 100-mm line, the length of which represents a continuum of an experience such as pain. Verbal descriptors mark the end of the continuum. The study team use the verbal descriptors 'no pain' and 'worst imaginable pain.'

Secondary

MeasureTime frameDescription
Stress Visual Analogue Scale (VAS)3 minutesThe VAS is a 100-mm line, the length of which represents a continuum of an experience such as stress. Verbal descriptors mark the end of the continuum. The study team use the verbal descriptors 'no stress' and 'extreme stress.'
Mood Visual Analogue Scale (VAS)3 minutesThe VAS is a 100-mm line, the length of which represents a continuum of an experience such as mood. Verbal descriptors mark the end of the continuum.The study team use the verbal descriptors 'best mood' and 'worst mood.'

Countries

United States

Contacts

Primary ContactLauren Fedpr, CCRP
fedor@rowan.edu856-566-6003

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026